CLINICAL_TRIALS trial_result · 2023-07-19

Clinical Trial Update: Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease [Phase 1, Phase 2]

Clinical trial update on ITF2357 for Crohn's disease, terminated after Phase 1/2; results posted but study ended.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Italfarmaco | Conditions: Crohn's Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-07-19